Christopher McFadden of Goldman Sachs points out that clients have started to claw back much of the lucrative sales rebate (some prefer to call it kickback) PBMs get from drugs manufacturers.

• GoldmanSachs的ChristopherMcfadden指出，客户开始取得药品津贴管理企业从药厂手里得到的销售返还（有人叫这个为回扣）。